February 2009
Edited
by:
Dennis Scott BVSc MACVSc
Ethical
Agents Ltd 54 Hobill Ave Wiri PO Box 97-110
Manukau City Manukau 2241
Ph 09-262-1388
Fax 09-262-1411 Freephone
0800 800-624
email eage@xtra.co.nz website
www.ethicalagents.co.nz
Inside this issue:
The efforts of Ethical Agents in the marketing of TriGene Advance in Australasia have been recognized by the parent company of the total TriGene range, MediChem UK, making the worldwide distribution award for 2008 to the New Zealand based company.
Considering the huge global success of TriGene Advance, with its patented nanotechnology this is quite an achievement and something the team at EA can justifiably be very proud of.
A look at generics, what they are and comparisons
Pollution in India - a major threat to antibiotic resistance
Log reductions and contact times
Being agents for some of the most original R&D from companies like Vétoquinol, Calolcompagniet and MediChem, Ethical Agents Ltd is uniquely placed to comment on generics and R&D.
Troy Laboratories in Australia, with their value added products such as Fiprovet and Propercillin, have shown that generics may even
surpass the reference product in performance.
Vétoquinol specialise in R&D and shy away from generics in general, but they have emphasised the fact that generics may give an advantage over just price with products such as Clavaseptin, which not only has the same bioavailability as the reference product but also better palatability
and smaller tablet size so has better owner compliance.
“The same but cheaper” line does not apply in these instances of extra points of difference.
Conversely that line does not apply when cheaper products are clearly not the same as the original in active ingredient formulation. These points are discussed inside.